Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity

Journal of Investigative Dermatology

Volumn 117, Issue 1, 2001, Pages 132-140

  Böhm, Markus ^d   Schulte, Ursula ^d   Funk, Jens Oliver ^a   Raghunath, Michael ^d   Behrmann, Iris ^b   Kortylewski, Marcin ^b   Heinrich, Peter C ^b   Kues, Thorsten ^c   Luger, Thomas A ^d   Schwarz, Thomas ^d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c INST OF REPRO MED OF THE UNIV   (Germany)

^d NONE

Author keywords

Cell cycle; Interleukin 6; Melanoma; Signal transducer and activator of transcription 3; Signal transduction

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN E; DNA; HISTONE H1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; STAT3 PROTEIN;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MELANOMA CELL; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0034947391     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2001.01372.x     Document Type: Article

References (57)

1. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinases kinase in vitro and in vivo
2. Down-regulation of interferon γ- activated STAT1 by UV light
3. High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas
4. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: Evidence for a dominant phenotype
5. The retinoblastoma protein pathway and the restriction point
6. Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells
7. RSK as the probable 133-Ser-CREB kinase in human melanocytes
8. Signal transducer and activator of transcription-3 serine phosphorylation by insulin is mediated by a Ras/Raf/MEK-dependent pathway
9. Specific inhibition of Stat3 signal transduction by PIAS3
10. Human cutaneous malignant melanoma as a model for cancer
11. Tumor progression and the nature of cancer
12. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression
13. STATs and gene regulation
14. Transformation of melanocytes with basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted environment
15. The early and intermediate precursor lesions of tumor progression in melanocytic system: Common acquired nevi and atypical (dysplastic) nevi
16. A new protein containing an SH2 domain that inhibits JAK kinases
17. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: Evidence for cooperation between p21Cip1/WAF1 and p27Kip1
18. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma
19. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
20. Inhibiting CDK inhibitors: New lessons from DNA tumor viruses
21. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation
22. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6
23. Cytoplasmic STAT proteins associate prior to activation
24. Growth factors and melanomas
25. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
26. Human melanoma: Development and progression
27. Growth regulatory factors for normal premalignant, and malignant human melanoma cells in vitro
28. Irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase
29. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation
30. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK)
31. Expression of multi-cytokine resistance and multi-growth Factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm
32. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1
33. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression
34. Interleukin 6: A fibroblast-derived growth inhibitor of human melanoma cells from early but nor advanced stages of tumor progression
35. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions
36. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130
37. Mammalian antiproliferative signals and their targets
38. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line
39. Principles of CDK regulation
40. An Hsp 70-like protein in the ER identity with the 78 kD glucose-regulated and immunoglobulin heavy chain binding protein
41. Transforming growth factor beta targeted inactivation of cyclin E. cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity
42. Structure and function of a new STAT-induced STAT inhibitor
43. The SOCS proteins: A new family of negative regulators of signal transduction
44. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo
45. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells
46. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases
47. Expression of activated N-ras in a primary melanoma line counteracts growth inhibition by transforming growth factor-β
48. Inhibitors of mammalian G1 cyclin-dependent kinases
49. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M
50. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components
51. A family of cytokine-inducible inhibitors of signalling
52. Identification by anti-idiotype antibodies of an intracellular membrane protein that recognizes a mammalian endoplasmic reticulum retention signal
53. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter
54. The retinoblastoma protein and cell cycle control
55. Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3
56. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation
57. Requirement of serine phosphorylation for formation of STAT-promoter complexes